Influenza Vaccination
Vaccine exemption rate rises among US kindergarteners

The rate of vaccine exemptions rose slightly among children entering kindergarten in the 2018-2019 school year, with 2.5% having an exemption from at least one vaccine, according to new data published in MMWR. But researchers suggested an additional target to improve vaccine coverage rates in the United States: underimmunized children who begin school under grace periods or provisional enrollment.
Maternal HIV infection may impact flu vaccine response in infants
In a study conducted among nearly 500 influenza vaccine-naive mother-infant pairs in Malawi, researchers found that maternal HIV infection was associated with lower antibody responses to influenza A viruses in both mothers and their infants, suggesting that influenza vaccines “may have variable efficacy in sub-Saharan Africa” where there is a high burden of HIV, researchers said.
Most pregnant women do not get flu, Tdap vaccines
Flu vaccine reduces risk for hospitalization in kids, death in adults
Cell- and egg-based flu vaccines provide similar immunogenicity, surprising researchers
Barely half of US adults plan to get flu vaccine, FDA OKs monkeypox, smallpox vaccine — top stories in infectious disease
‘Explain the science’: PCPs can improve flu vaccine uptake among pregnant women
Only 52% of US adults plan to get flu vaccine, survey shows
Supportive care measures underused among older patients with multiple myeloma
Preventing and treating flu in immunocompromised patients: 2019-2020 update

Influenza remains an important threat to public health, and people with impaired immune systems are at particularly high risk for severe disease and complications. One comparative analysis showed that severely immunocompromised patients with influenza experienced significantly more hospitalizations, ICU admissions and mechanical ventilation than nonimmunocompromised patients. However, clinical signs and symptoms may be pronounced on initial presentation, underscoring the importance of seeking early medical attention. Additionally, antiviral resistance is more common and the mean viral shedding time was longer among immunocompromised patients (19 days compared with 6.4 days in healthy people).